|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.33 CAD | 0.00% |
|
-1.49% | -15.38% |
| Apr. 25 | Microbix to Present New Lab Accreditation Program at European Congress on Clinical Microbiology | MT |
| Apr. 25 | Microbix Collaborator Introduces New Lab Accreditation Program | CI |
Microbix Biosystems Inc. provided earnings guidance for the fiscal year 2022. For the year, the company excepts that fiscal 2022 will realize materially-positive net earnings, as were achieved in fiscal 2021.
| 1st Jan change | Capi. | |
|---|---|---|
| -15.38% | 33.19M | |
| +17.96% | 44.96B | |
| +1.17% | 42.65B | |
| +48.77% | 41.85B | |
| -4.27% | 29.04B | |
| +11.42% | 26.08B | |
| -21.39% | 19.03B | |
| +4.86% | 12.75B | |
| +27.29% | 12.06B | |
| -3.50% | 11.75B |
MICROBIX BIOSYSTEMS INC. 
